CJC-1295/Ipamorelin W/O DAC

CJC-1295 (without DAC) and Ipamorelin are synthetic peptides commonly studied for their interaction with growth hormone signaling pathways. CJC-1295 acts as a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is a growth hormone secretagogue that interacts with ghrelin receptors. Together, they are frequently investigated in laboratory settings for their effects on endogenous growth hormone release and neuroendocrine signaling.

Summary

CJC-1295/Ipamorelin (without DAC) is commonly utilized in research exploring growth hormone regulation, endocrine function, and cellular signaling mechanisms.

For Research Use Only. The information provided is for educational and informational purposes only. CJC-1295/Ipamorelin (without DAC) is not FDA-approved, is not intended for human consumption, and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.